
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Sanofi
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Case study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.
Recruitment study tests the use of a ride-sharing service.
Published: December 1st 2019 | Updated:
Published: March 1st 2020 | Updated: